Shares of Gilead Sciences were downgraded on Monday by not one but two firms, BMO Capital and Wells Fargo. The biotech giant was downgraded by the analysts who said it is fully valued amid market enthusiasm for its drug candidate to treat COVID-19, remdesivir. BMO Capital’s Matthew Luchini downgraded the stock to market perform from … Continue reading “Gilead Sciences Gets a Downgrade from BMO Capital and Wells Fargo”
Biotech & Pharma
Biotech & Pharma
Abbott Gets Approval for a Coronavirus Test that Can Get Results in 5 Minutes
One of the biggest issues with the coronavirus pandemic is that there are not enough…
March 30, 2020
Biotech & Pharma
A Japanese Flu Drug May Be Able to Treat Coronavirus
According to an NHK report, there is a Japanese flu drug that could be effective…
March 19, 2020
Biotech & Pharma
Revolution Medicines Inc. Explodes on First Day of Trading
Clinical stage oncology company Revolution Medicines, Inc. made its debut in the stock market on…
February 14, 2020
Biotech & Pharma
Aimmune Shares Explode on Peanut Allergy Treatment Approval from FDA
Aimmune Therapeutics saw its shares flying on Monday after the company gained Food and Drug…
February 3, 2020
Biotech & Pharma
Novavax Initiates Development of Vaccine for Wuhan Coronavirus
Novavax, a clinical-stage vaccine company headquartered in Gaithersburg, Maryland, saw its shares explode 60% in…
January 23, 2020
Biotech & Pharma
Clovis Oncology Shares Soar on Positive FDA News
Shares of biopharmaceutical company Clovis Oncology were soaring on Wednesday after the company said the…
January 16, 2020
Biotech & Pharma
Innate Pharma Explodes on Leukemia Drug Submission in Europe
Shares of French biotech company Innate Pharma SA were on the rise on Thursday in…
January 3, 2020
Biotech & Pharma
Pulmatrix Inc. Scores Licensing Agreement with Johnson & Johnson
Clinical stage biopharmaceutical company Pulmatrix has announced a licensing agreement with Johnson & Johnson this…
January 3, 2020
Biotech & Pharma
Spectrum Pharmaceuticals Sees its Worst Day in 17 Years
Biopharma company Spectrum Pharmaceuticals were crashing on Thursday after the company said a mid-stage trial…
December 27, 2019
Biotech & Pharma
Sarepta Therapeutics Announces Partnership With Roche to Sell Key Gene Therapy
Shares of Sarepta Therapeutics were gaining this week after Wall Street learned that the company…
December 25, 2019
Biotech & Pharma
The FDA Suddenly Approves This Drug From Sarepta Therapeutics
Shares of Sarepta Therapeutics were on the rise after the Food and Drug Administration (FDA)…
December 14, 2019
Biotech & Pharma
Sorrento Therapeutics Turns Down Unsolicited Offer
Shares of Sorrento Therapeutics were pulling back after almost doubling this week on reports that…
November 28, 2019
Biotech & Pharma
Global Blood Lands FDA Approval for Pill to Treat Sickle Cell Disease
Shares of Global Blood were jumping over 10% this week on news that the company…
November 28, 2019